Amidst an uptick of fresh COVID-19 cases in the country, the Drugs Controller General of India (DCGI) on Tuesday approved the emergency use authorisation for two anti-coronavirus vaccines in children between 5 and 12 years, senior officials in the Health Ministry confirmed.
The move comes even as several State governments are now reimplementing COVID-19 protocols and Prime Minister Narendra Modi is scheduled to hold a meeting with Chief Ministers on April 27 on the emerging COVID-19 situation.
Biological E’s Corbevax has been approved for administration in children between the ages of 5 and 12 and Bharat Biotech’s Covaxin has been approved for restricted use in emergency situations in children aged 6-12.